NCT07369180
NQ Square TMS for MDD 1Dx3S Adults Multi-site Sham-controlled Protocol
Enrolling by Invitation
NAAges 22–85InterventionalTreatmentNeuroQore Inc.
~37 participants
Updated 2026-01-27 on ClinicalTrials.gov
What's tested:Active Accelerated rTMS TreatmentSham Accelerated rTMS Treatment
At a glance
Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
MADRS Score
Measured over From enrollment to final MADRS score assessment within 6 weeks.
Conditions
Where it's being run
2 sites across 1 statesCalifornia2
Study leadership
- Karthik Ramgopal, DO · PRINCIPAL_INVESTIGATOR · LGTC Group
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- MADRS ScoreFrom enrollment to final MADRS score assessment within 6 weeks.
Change in MADRS score from baseline to immediately post treatment, 24 hours, 7 days and 30 days post-treatment.